Development and Validation of a Transfusion Risk Score for Patients Receiving Maintenance Hemodialysis

Area of Science:

• Nephrology
• Hematology
• Biostatistics

Background:

• Avoiding red blood cell transfusions is crucial for patients with anemia undergoing dialysis.
• A need exists for a reliable method to predict transfusion risk in this population.
• This study aimed to develop and validate a novel transfusion prediction risk score for maintenance hemodialysis patients.

Purpose of the Study:

• To develop and validate a predictive risk score for red blood cell transfusions in patients on maintenance hemodialysis.
• To identify key clinical variables associated with transfusion risk.
• To explore the score's association with hospitalization and mortality.

Main Methods:

• Retrospective cohort study using United States Renal Data System data.
• Development and validation cohorts established based on dialysis status at specific dates.
• Logistic least absolute shrinkage and selection operator regression used to identify predictive variables (prior transfusion, hemoglobin, ferritin, hospital days) for 3-month transfusion risk.

Main Results:

• The developed risk score demonstrated good predictive power in the validation cohort (c-statistic = 0.74).
• Key predictors included prior transfusion, hemoglobin, ferritin, and baseline hospital days.
• The score was significantly associated with increased subsequent mortality risk but not hospitalization.

Conclusions:

• A transfusion prediction risk score with good performance characteristics was developed for hemodialysis patients.
• The score's association with mortality suggests its potential utility in clinical decision-making.
• This tool could facilitate proactive anemia management to avoid transfusions and adverse outcomes.